Senate testimony by President & CEO Chris Collins in support of the Global Fund (fiscal year 2027)
Written testimony submitted by Chris Collins, president and CEO of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria,...
Written testimony submitted by Chris Collins, president and CEO of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria,...
What it will take to make Secretary Rubio’s vision for global health aid transition a reality By Chris Collins Transitioning U.S....
This map shows the Global Fund’s return on investment to US businesses. Specifically, it details the amount of money made...
My kids survived the AIDS crisis. These children may not. By Maurine Murenga In the early 2000s, death was everywhere...
Protecting civil society’s critical role in HIV and TB programs during and beyond donor transition: Actions needed from Congress, the Administration...
Promising practices in advocacy for domestic health spending As countries continue to transition away from donor funding for health programs,...
Statement on the National Security, Department of State, and Related Programs Appropriations Bill Below is a statement from Friends President...
Private sector urges Congress for robust investment in the Global Fund Today, seventeen companies sent a letter to the Chairs...
Written Testimony submitted by Chris Collins, president and CEO of Friends of the Global Fight Against AIDS, Tuberculosis and Malaria,...
Sustaining progress against AIDS, tuberculosis and malaria as countries transition to growing self-reliance: The crucial role for Congress in protecting...
Blog: Making Country-Led Malaria Transitions Sustainable By Isabella Castillo As global health financing shifts toward greater country ownership, the question...
Issue brief: HIV in 2026 Click here to download our new two-page issue brief